Literature DB >> 20380815

MicroRNAs and deregulated gene expression networks in neurodegeneration.

Kai-Christian Sonntag1.   

Abstract

Neurodegeneration is characterized by the progressive loss of neuronal cell types in the nervous system. Although the main cause of cell dysfunction and death in many neurodegenerative diseases is not known, there is increasing evidence that their demise is a result of a combination of genetic and environmental factors which affect key signaling pathways in cell function. This view is supported by recent observations that disease-compromised cells in late-stage neurodegeneration exhibit profound dysregulation of gene expression. MicroRNAs (miRNAs) introduce a novel concept of regulatory control over gene expression and there is increasing evidence that they play a profound role in neuronal cell identity as well as multiple aspects of disease pathogenesis. Here, we review the molecular properties of brain cells derived from patients with neurodegenerative diseases, and discuss how deregulated miRNA/mRNA expression networks could be a mechanism in neurodegeneration. In addition, we emphasize that the dysfunction of these regulatory networks might overlap between different cell systems and suggest that miRNA functions might be common between neurodegeneration and other disease entities. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20380815      PMCID: PMC2883630          DOI: 10.1016/j.brainres.2010.03.106

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  83 in total

1.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.

Authors:  Eugene V Makeyev; Jiangwen Zhang; Monica A Carrasco; Tom Maniatis
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

Review 2.  The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death.

Authors:  Andrea C LeBlanc
Journal:  Curr Alzheimer Res       Date:  2005-10       Impact factor: 3.498

Review 3.  MicroRNA function in neuronal development, plasticity and disease.

Authors:  Roberto Fiore; Gabriele Siegel; Gerhard Schratt
Journal:  Biochim Biophys Acta       Date:  2008-01-14

4.  A MicroRNA feedback circuit in midbrain dopamine neurons.

Authors:  Jongpil Kim; Keiichi Inoue; Jennifer Ishii; William B Vanti; Sergey V Voronov; Elizabeth Murchison; Gregory Hannon; Asa Abeliovich
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

5.  Foxa1 and Foxa2 function both upstream of and cooperatively with Lmx1a and Lmx1b in a feedforward loop promoting mesodiencephalic dopaminergic neuron development.

Authors:  Wei Lin; Emmanouil Metzakopian; Yannis E Mavromatakis; Nan Gao; Nikolaos Balaskas; Hiroshi Sasaki; James Briscoe; Jeffrey A Whitsett; Martyn Goulding; Klaus H Kaestner; Siew-Lan Ang
Journal:  Dev Biol       Date:  2009-07-14       Impact factor: 3.582

6.  MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1.

Authors:  Vincent Boissonneault; Isabelle Plante; Serge Rivest; Patrick Provost
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

7.  An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP.

Authors:  Gary A Wayman; Monika Davare; Hideaki Ando; Dale Fortin; Olga Varlamova; Hai-Ying M Cheng; Daniel Marks; Karl Obrietan; Thomas R Soderling; Richard H Goodman; Soren Impey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-24       Impact factor: 11.205

Review 8.  MicroRNAs (miRNAs) in neurodegenerative diseases.

Authors:  Peter T Nelson; Wang-Xia Wang; Bernard W Rajeev
Journal:  Brain Pathol       Date:  2008-01       Impact factor: 6.508

9.  A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis.

Authors:  Gabriele Siegel; Gregor Obernosterer; Roberto Fiore; Martin Oehmen; Silvia Bicker; Mette Christensen; Sharof Khudayberdiev; Philipp F Leuschner; Clara J L Busch; Christina Kane; Katja Hübel; Frank Dekker; Christian Hedberg; Balamurugan Rengarajan; Carsten Drepper; Herbert Waldmann; Sakari Kauppinen; Michael E Greenberg; Andreas Draguhn; Marc Rehmsmeier; Javier Martinez; Gerhard M Schratt
Journal:  Nat Cell Biol       Date:  2009-05-24       Impact factor: 28.824

10.  MicroRNAs can regulate human APP levels.

Authors:  Neha Patel; David Hoang; Nathan Miller; Sara Ansaloni; Qihong Huang; Jack T Rogers; Jeremy C Lee; Aleister J Saunders
Journal:  Mol Neurodegener       Date:  2008-08-06       Impact factor: 14.195

View more
  60 in total

Review 1.  Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation.

Authors:  Liqin Du; Alexander Pertsemlidis
Journal:  J Mol Cell Biol       Date:  2011-01-28       Impact factor: 6.216

2.  Growth inhibition by miR-519 via multiple p21-inducing pathways.

Authors:  Kotb Abdelmohsen; Subramanya Srikantan; Kumiko Tominaga; Min-Ju Kang; Yael Yaniv; Jennifer L Martindale; Xiaoling Yang; Sung-Soo Park; Kevin G Becker; Murugan Subramanian; Stuart Maudsley; Ashish Lal; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

3.  Effect of (S)-3,5-DHPG on microRNA expression in mouse brain.

Authors:  Theresa A Lusardi; Simon J Thompson; Ian C MacDonald; Jing-Quan Lan; Panos Theofilas; Julie A Saugstad
Journal:  Exp Neurol       Date:  2012-01-28       Impact factor: 5.330

4.  HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.

Authors:  J Robert Chang; Ruma Mukerjee; Asen Bagashev; Luis Del Valle; Tinatin Chabrashvili; Brian J Hawkins; Johnny J He; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

Review 5.  MicroRNAs in neurodegenerative diseases and their therapeutic potential.

Authors:  Eunsung Junn; M Maral Mouradian
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

6.  Traceable microRNA-124 loaded nanoparticles as a new promising therapeutic tool for Parkinson's disease.

Authors:  Cláudia Saraiva; Lino Ferreira; Liliana Bernardino
Journal:  Neurogenesis (Austin)       Date:  2016-11-14

7.  Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.

Authors:  Ruma Mukerjee; J Robert Chang; Luis Del Valle; Asen Bagashev; Monika M Gayed; Randolph B Lyde; Brian J Hawkins; Eugen Brailoiu; Eric Cohen; Chris Power; S Ausim Azizi; Benjamin B Gelman; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

8.  Microdissection and transcriptional profiling: a window into the pathobiology of preclinical prion disease.

Authors:  Anna Majer; Stephanie A Booth
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

9.  Up-regulation of the mitochondrial malate dehydrogenase by oxidative stress is mediated by miR-743a.

Authors:  Qingli Shi; Gary E Gibson
Journal:  J Neurochem       Date:  2011-06-24       Impact factor: 5.372

10.  miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

Authors:  Woori Kim; Yenarae Lee; Noah D McKenna; Ming Yi; Filip Simunovic; Yulei Wang; Benjamin Kong; Robert J Rooney; Hyemyung Seo; Robert M Stephens; Kai C Sonntag
Journal:  Neurobiol Aging       Date:  2014-01-24       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.